[EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update].

@article{Babjuk2012EAUGO,
  title={[EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update].},
  author={M. Babjuk and W. Oosterlinck and R. Sylvester and E. Kaasinen and A. B{\"o}hle and J. Palou-Redorta and M. Roupr{\^e}t},
  journal={Actas urologicas espanolas},
  year={2012},
  volume={36 7},
  pages={
          389-402
        }
}
CONTEXT AND OBJECTIVE To present the 2011 European Association of Urology (EAU) guidelines on non-muscle-invasive bladder cancer (NMIBC). EVIDENCE ACQUISITION Literature published between 2004 and 2010 on the diagnosis and treatment of NMIBC was systematically reviewed. Previous guidelines were updated, and the level of evidence and grade of recommendation were assigned. EVIDENCE SYNTHESIS Tumours staged as Ta, T1, or carcinoma in situ (CIS) are grouped as NMIBC. Diagnosis depends on… Expand
EDITORIAL COMMENT
How well can you actually predict which non-muscle-invasive bladder cancer patients will progress?
High-risk non-muscle-invasive bladder cancer: update for a better identification and treatment
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 80 REFERENCES
High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder.
A second-look TUR in T1 transitional cell carcinoma: why?
Significance of Bladder Biopsies in Ta,T1 Bladder Tumors: A Report from the EORTC Genito-Urinary Tract Cancer Cooperative Group
Urine markers for bladder cancer surveillance: a systematic review.
...
1
2
3
4
5
...